1.

治疗前后FBG、2 hPBG、FINS、2 hPINS、F-CP、2 hP-CP、HbA1c以及HOMA-β、HOMA-IR变化

Changes in the observed clinical parameters in the patients after the treatment (Mean±SD, n=54)

Group	Before treatment	After treatment	Variation	P
HbAlc:Hemoglobin Alc; FBG:Fasting blood glucose; FINS:Fasting insulin; F-CP:Fasting C-peptide; 2 hPBG: 2 hours postprandial blood glucose; 2 hPINS:2 hours postprandial insulin; 2 hP-CP:2 hours postprandial C-peptide; HOMA-β:Homa beta cell function index; HOMA-IR:Homa insulin resistance index.
HbA1c (%)	10.55±1.02	6.36±0.67	4.19±1.07	0.000
FBG (mmol/L)	13.65±3.87	6.79±1.25	6.86±3.83	0.000
FINS (mU/L)	7.79±3.73	7.09±2.96	0.70±2.82	0.074
F-CP (μg/L)	2.04±0.85	1.98±0.67	0.06±0.69	0.548
2 hPBG (mmol/L)	21.88±5.66	8.43±2.41	13.45±5.51	0.000
2 hPINS (mU/L)	20.96±15.26	20.65±11.70	0.31±12.55	0.858
2 hP-CP (μg/L)	3.86±1.77	4.40±1.61	-0.54±1.39	0.006
HOMA-β (%)	18.62±13.71	48.91±26.41	-30.29±21.99	0.000
HOMA-IR	4.61±2.30	2.16±1.09	2.45±1.89	0.000